CymaBay Therapeutics started at outperform with $35 stock price target at Evercore ISI

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.



http://on.mktw.net/2CgrvfX

Source: Market Watch

Leave a Reply

Your email address will not be published. Required fields are marked *